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BROMOTRICHLOROMETHANE (CBrC13) treatment is a model for
studies on molecular mechanisms of haloalkane toxicity
with some advantages compared with CC14 treatment. The
formation of4-hydroxynonenal and similar aldehydic pro-
ducts of lipid peroxidation, which play a role as mediators
of inflammatory processes, was clearly demonstrated in rat
hepatocytes treated with CBrCI3. It may be assumed that
haloalkane toxicity is connected with the biological effects
of those inflammation mediatory aldehydic compounds.
Key words: Aldehydes, Bromotrichloromethane, Haloalkanes,
Hepatocytes, 4-Hydroxynonenal, Lipid peroxidation
Formation of
4-hydroxynonenal and further
aldehydic mediators of
inflammation during
bromotrichlorornethane
treatment of rat liver cells
Olaf Sommerburg, Tilman Grune,
Sabine Klee,2 Fritz R. Ungemach2 and
Werner G. Siemsz’cA
1Institute of Biochemistry, Medical Faculty
(Charit6), Humboldt University Berlin,
D(O),-1040 Berlin, Hessische Str. 3-4, Germany
and Zlnstitute of Veterinary Pharmacology and
Toxicology, Free University Berlin, D-1000 Berlin
33, Koserstr., Germany
3Herzog-Julius-Hospital, D-3388 Bad Harzburg,
Kurhausstr, 13-17, Germany
CA Corresponding Author
Introduction
Although pathophysiological and biochemical
changes due to haloalkane intoxication have been
investigated intensively by many laboratories,
increasing exposure to toxic pollutants in the
workplace and in the environment requires the
continuation of studies on the molecular basis of
haloalkane toxicity. Haloalkanes are also of
importance in clinical practice because of the use of
halothane and other halogenated compounds as
inhalation anaesthetics, and a number of clinical
cases of CC14 poisoning. Additionally 1,2-di-
bromomethane has been used as a fruit and grain
fumigant.
Haloalkanes induce serious inflammatory reac-
tions. Several reports exist on biochemical changes
in plasma during halothane treatment characterizing
these inflammatory reactions, 1’2 and on hepatitis and
cirrhosis after halothane or CC14 intoxication. The
cytotoxic mechanisms of haloalkanes have been
studied mostly in cell suspensions, organs or whole
animals treated with CC14. CBrC13 was also used
several times for investigations on haloalkane
toxicity. CC14 is metabolized in a cytochrome P-450
dependent reaction which leads to the formation of
the "CC13 radical. The "CC13 radical rapidly interacts
with membrane lipids.
4-7 The "CC13 induced lipid
peroxidation following CC14 treatment is con-
siderably lower than that induced by CBrC13
treatment. It is known that the C-C1 cleavage needs
more energy (68 kcal/mol) than the cleavage of the
C-Br bond (49 kcal/mol). Koch et al. investigated
comparatively the capacity of CC14 and CBrC13 to
induce lipid peroxidation. In vitro, CBrC13 induced
lipid peroxidation was about 100 times more
effective than the CC14 induced lipid peroxidation;
and in vivo was three times more effective. That
favours the CBrC13 model for studies on cytotoxic
effects of haloalkanes in comparison with the CC14
model.
The most common parameter for the measure-
ment of lipid peroxidation and its products is the
generation of malondialdehyde (MDA) in exposed
systems. However, the various procedures ofMDA
determination produce different results.1 Further-
more, those methods are rather unspecific for the
free metabolite MDA. The determination of other
aldehydes--e.g. 4-hydroxynonenal (HNE), as the
main representative of 4-hydroxyalkenales--is a
more specific and sensitive method for the
estimation of lipid peroxidation. It is known that
4-hydroxynonenal and some other aldehydic
products of lipid peroxidation are much more
effective as inflammatory agents, e.g. as chemo-
attractive substances, than MDA.
2 Poli et al.
determined the formation of various aldehydic
products of lipid peroxidation during CC14
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treatment in hepatocyte suspensions.
13 MDA
formation was measured in CBrC13 treated cells
too,4’5’14 but there are no data on the formation of
4-hydroxyalkenales and further aldehydic products
of lipid peroxidation except MDA in CBrC13 treated
cells, organs or animals. This paper deals with the
determination of such highly reactive mediators of
inflammation in the CBrCI intoxication model.
Materials and Methods
Chemicals: Aldehyde standards (dinitrophenylhydra-
zones) were prepared in the laboratory of Prof. H.
Esterbauer, Karl-Franzens University Graz,
Austria. The solvents n-hexane, acetonitrile,
dichloromethane, methanol and benzene, and the
TLC plates (silica gel 60, 0.2 mm thickness) were
from Merck (Darmstadt, Germany). 2,4-Dinitro-
phenylhydrazine (DNPH) was obtained from
Union Chimique (Brussels, Belgium). DNPH was
dissolved in 5ml of 1 M hydrochloric acid,
extracted with 3 x 5 ml of n-hexane, then adjusted
to 1.8 mM solution with 1 M hydrochloric acid by
means of absorbance measurement at 378 nm.
Collagenase (Clostridium histoticum) was from
Boehringer (Mannheim, Germany). All other
reagents were purchased from Sigma Chemie
GmbH (Deisenhofen, Germany). Thiobarbituric
acid and malondialdehyde diethylacetal were
obtained from Aldrich Chemie GmbH (Steinheim,
Germany).
Cell preparation: Male Wistar H-strain rats with a
body weight of about 230 g were used. Hepatocytes
were prepared according to the method given in
Berry and Friend
is with modifications given in
Vincent6. Starved rats (24 h) were anaesthetized by
an intraperitoneal injection pentobarbital (30 mg/kg
body wt.). As perfusion medium a Krebs-Henseleit
bicarbonate buffer gassed with O2: CO2 (19 1) was
used.
Cell incubation: The cell viability was determined by
cell staining with trypan blue. Only hepatocyte
suspensions with more than 85% of viable cells
excluding trypan blue were used for experiments.
The cell suspensions were adjusted to a cytocrit of
2% (v/v) (5.2 x 106 cells/ml) with Krebs-Henseleit
buffer as the incubation medium. The cells were
incubated at 37C under continuous gyratory
shaking. CBrCI dissolved in ethanol was added in
a final concentration of 1 mM. The controls were
treated with the same amount of ethanol (1% final
concentration). The aldehydic formation in hepato-
cyte suspensions induced by 1 mM CBrCI was
compared with aldehyde formation in hepatocyte
suspensions which were incubated in presence of
1 mM CC14 under the same conditions of prepara-
tion, incubation, extraction and analysis.
3
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Determination of4-hydroxynonenal andfurther aldehydes: The
detection of aldehydes was performed according to
Esterbauer et al.: and Poli et al.
Derivatization ofaldehydes with DNPH: 2.5 ml of the cell
suspension reacted with 2.5 ml of DNPH solution
(1.8 mM in 1 N HCl) in the presence of butylated
hydroxytoluene (BHT) (final concentration 10 mM)
for 2 h in the dark. Thereafter, the sample was kept
on ice for i h in the dark, then extracted three times
with 8 ml of dichloromethane and centrifuged at
900 x g. The supernatant was evaporated on a
rotary evaporator to dryness at 33C. The residue,
dissolved in 1 ml of dichloromethane, was trans-
ferred into small vials for spotting on TLC
plates.
Thin-layer chromatography: The TLC plates were
developed with dichloromethane in comparison
with known standards. By this method according
to details given in Esterbauer et al.
7 the dini-
trophenylhydrazones of carbonyl compounds were
separated into three zones. Zone I contained the
4-hydroxyalkenales. Zone I and Zone III were
scraped off, each extracted three times with 10 ml
of methanol and evaporated to dryness. The residue
was dissolved in 1 ml of methanol.
HPLC equipment and chromatographic conditions: A HPLC
system from Perkin Elmer was used consisting of
a M410 pump system, a LC 95 variable wavelength
detector, a LCI-100 integrator and a Rheodyne
injector. For some determinations a Photodiode-
Array-Detector (Hewlett-Packard) was used addi-
tionally.
TM The eluent for the isocratic separation
was methanol-water (4:1, v/v), at a flow rate of
1 ml/min. A Nucleosil 5C18 column (Macherey,
Nagel & Co., Diiren, Germany, 250 x 4.0 mm
I.D.) was used, with a 20 x 4.0mmI.D. pre-
column. Peak identification was performed by
comparison of the retention times of peaks of
biological extracts and of standard extracts, and also
by the coelution of biological extracts with the
reference compound and by comparison of the
spectra of the analytes. Quantification ofHNE was
achieved by separating HNE-DNPH standard
solutions of different concentrations. Quantification
of further aldehydes was also performed using
different concentrations of their dinitrophenylhy-
drazone derivatives.
Recovery" The recovery was determined using a HNE
standard solution (10M) and amounted to
32 +/- 5% (mean + S.D.). The value of HNE
recovery was highly reproducible. Recoveries of
other carbonyls were quantified in an analogous
manner. All recoveries were between 25 and 40%.
The values of HNE and other aldehydes were
corrected to 100%.Aldehydes during haloalkane intoxication
Determination of malondialdehyde (MDA): MDA was
measured according to Wong et a/. 19 A 200
sample of cell suspension was mixed with 0.75 ml
phosphoric acid (0.44 mol/1), 0.25 ml thiobarbituric
acid (42 mmol/1) and 0.3 ml water and boiled for
60 min. The reaction was stopped by cooling the
samples in an ice bath. Immediately before HPLC
analysis an equal volume of i M NaOH was added
followed by centrifugation. The HPLC system
consisted of a Waters 510 pump, a Shimadzu
fluorescence detector RF-530 (525/550 nm) and a
C-R6A integrator. The column was a Supelcosil
150 x 4 mm LC-18-S (5 [tM). As eluent, a 50 mM
potassium phosphate buffer solution (pH 6.8) with
40% methanol was used.
Results
In this study of HNE,, MDA and further
aldehydic products of lipid peroxidation could be
detected and quantitatively evaluated in the samples
of hepatocyte suspensions. There were no differ-
ences between HNE levels of controls and CBrC13
treated cells at time zero of the experiments (Fig.
1). The HNE concentration of control suspension
was constant during 1 hr of incubation. The
HNE level was about 200nmol/1 suspension
(0.2/,M). In the case of CBrC13 treatment, 5 min
after the addition of haloalkane to the cell
suspension the HNE level was markedly increased.
The HNE value at this time point was about
600 nmol/1 cell suspension. This three-fold increase
in the HNE level was maintained throughout the
whole experiment. There was even a trend for a
further slight increase between 45 and 60 min after
CBrC13 addition.
Figure 2 shows the changes of MDA concentra-
tion in CBrC13 treated hepatocyte suspensions. The
level of MDA at time zero was about 800 nmol/1
cell suspension (0.8#M). There was a slight
decrease of MDA level in control suspensions
during the first 15 min of incubation. Therefore, the
0
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FIG. Concentration of 4-hydroxynonenal in hepatocyte suspensions
after bromotrichloromethane treatment. Symbols are: [] Control (addition
of ethanol), I bromotrichloromethane treatment (1 mM). Values are
given as mean -t-_ S.D. (*p < 0.05 as compared with controls).
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FIG. 2 Concentration of thiobarbituric acid--reactive substances in
hepatocyte suspensions after bromotrichloromethane treatment. Symbols
are" [] Control (addition of ethanol), [] bromotrichloromethane
treatment (1 mM). Values are given as mean ___S.D. (*p<0.05 as
compared with controls).
Table 1. Levels of aldehydic products of lipid
peroxidation in hepatocyte suspensions treated
60min with mM CBrCI3. Values are given as
nmol/I cell suspension" mean-t-S.D. (six experi-
ments)
Aldehyde 0 min 60 min
MDA 782 _+ 385 1180 + 355
HN E 190 +_ 70 900 -I- 160
Hexadienal 2.4 _+ 1.0 6.3 _+ 1.8
Heptadienal 0.6 -t- 0.6 6.0 +_ 1.0
Nonadienal 7.5 ___
2.6 11.7 _+ 2.2
Decadienal 13.2 -I- 4.0 24.2 +_ 4.4
Pentanal 9.3 -I- 1.7 27.1 _+ 2.9
Heptanal 26.0 +__ 5.4 40.7 -I- 4.0
control values of MDA level were in the range of
0.5 to 0.8 tM. CBrC13 treatment increased the MDA
concentration within 15 min (about twice the initial
value). Table 1 represents data on the further
aldehydic products of lipid peroxidation during
60 min of CBrC13 treatment of hepatocyte suspen-
sions. It was possible to detect low amounts of such
aldehydic compounds in CBrC13 treated cells. In
Fig. 3 the accumulation of MDA, HNE, pentanal
and heptanal in CC14 and in CBrC13 treated
hepatocyte suspensions is compared.
2
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FIG. 3 Concentration ratios of aldehydes after 60 min of incubation with
[] CBrCI3 and [] CCI4 (see Reference 13) compared with the initial
concentration in the same suspension.
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Discussion
Pathophysiological role of aldehydic products of lipid
peroxidation: There is increasing evidence that
aldehydes generated during the process of lipid
peroxidation are causally involved in some of the
pathophysiological effects associated with oxidative
stress in cells and tissues.2 Unlike reactive free
radicals, aldehydes are rather long-lived and can
therefore diffuse from the site of their origin, i.e.
membranes, and reach and attack targets in-
tracellularly or extracellularly which are distant
from the initial free radical event. HNE and similar
aldehydic products of lipid peroxidation exhibit a
wide spectrum of cytotoxic effects as well as
mutagenic and genotoxic effects,e-23
Since HNE, and other aldehydes, are formed
during the acute phase of inflammation they may
play a role as mediators in the inflammatory
process.
2 HNE effects produced even at HNE
concentrations of0.1/M or less include stimulation
of chemotactic oriented migration of neutro-
phils, 12’24’2s modulation of adenylate cyclase activity,
weak stimulation of guanylate cyclase
26 and
stimulation of phospholipase C.
iv Phospholipase C
is important for signal transduction by G-proteins.
Stimulation of phospholipase C leads to increased
hydrolysis of phosphatidyl-4,5-bisphosphate with
concomitant formation of diacylglycerol and
inositol triphosphate. Diacylglycerol acts syn-
ergistically with inositol triphosphate in the calcium
dependent activation of protein kinase C. Inositol
triphosphate opens calcium channels, whereas
diacylglycerol increases the calcium affinity of
protein kinase C. Protein kinase C plays an
important role in the control of cell division, cell
proliferation and other cellular functions. Phospho-
lipase C stimulation may also be responsible for the
chemotactic effects of 4-hydroxynonenal since it is
known that the chemotactic signal of f-met peptides
also results in an activation of phospholipase.
28
4-Hydroxyalkenals induce the oriented migration
and morphological polarization of neutrophils in
a concentration range of 10
-6 to 10-12M
depending on the chain length of the aldehyde. The
most effective aldehyde was not HNE but
4-hydroxyoctenal with a maximum chemotactic
activity at 10
-1 M. For HNE the effective doses
for chemotactic effects and for activation of
phospholipase C are between 10
-6 and 10
-9 M.
2s
Cytotoxic haloalkane effects depend on the
formation and action of free radicals initiating
lipid peroxidation.4’5’29 The formation of HNE
and similar aldehydic products of lipid peroxidation
in hepatocytes treated with CC14 was published by
Poli et al. In the present study the formation of
such compounds could also be demonstrated for
CBrCI.
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Critical aspects of methodological approach: For the
determination of long chain aldehydes a number Of
methods, such as the dinitrophenylhydrazine
method, the direct determination by HPLC, the
cyclohexadione method and the determination by
GC-MS, are described in Esterbauer and Zollner.
The determination of a wide spectrum of aliphatic
aldehydes is only possible, using the dini-
trophenylhydrazine and the cyclohexadione me-
thod, with comparable results in recovery and
reproducibility. The literature results for reproduc-
ibility and low recovery (about 40%) are in
accordance with those achieved in this study.’
The determination of the relatively low recoveries
for each aldehyde allows the determination of the
real biological steady state concentration in the cell
suspension. Nevertheless, the low recovery and
therefore a certain inaccuracy of methods which
were available for aldehyde analysis modify the
quantitative aspect of those measurements.
Compar#on of formation of aldehydes as mediators of
inflammation in CC14 and CBrC13 toxicity: The initial
levels of MDA and of HNE at zero time were in
the same range as concentrations reported by other
authors in hepatocyte suspensions.
13 In contrast to
CC14 treated cells the aldehyde levels increased very
rapidly, i.e. within the first minutes following
CBrCI addition to the hepatocytes. However, the
increases of MDA and HNE levels in hepatocyte
suspensions treated with CBrCI were in the same
range as in those hepatocyte suspensions treated
with equimolar concentrations of CC14 .13 The
increase of some aldehydic products of lipid
peroxidation within 1 h of treatment with CC14 or
CBrCI in comparison to initial levels is demon-
strated in Fig. 3. The most interesting point of this
comparison seems to be the excessive increase of
HNE as a very cytotoxic and chemotactic
compound at CBrCI loading compared with CC14
loading.
The generation of aldehydic products of lipid
peroxidation other than MDA and HNE could be
demonstrated for CBrC13 incubations (Table 1) but
at markedly lower concentrations than those for
MDA and HNE. Nevertheless, the amounts of
these aldehydes and ofHNE which were produced
even during short-term experiments are high
enough for the initiation of chemotactic activity
towards neutrophils.
It should be mentioned that the determined
aldehyde concentrations represent, of course, the
steady state concentrations, resulting from a con-
tinuous formation of the aldehydes and a con-
sumption of these compounds by the hepatocytes.
The HNE metabolism--including that in hepato-
cytes--was investigated in several studies.1’2-5 In
general the maximal capacity of tissues toAldehydes during haloalkane intoxication
metabolize aldehydes, especially HNE, is in the
order of several micromoles per gram wet weight
per minute, which is about six orders higher than
the accumulation within the first minutes after
haloalkane treatment.
The specific pattern of aldehydes formed by
CBrC13 and CC14 is different, whereas the overall
increase in MDA and HNE is comparable for both
compounds. The differences in lifetime, reactivity
and ’consumption’ rate of aldehydes may implicate
differences in the pattern of cell and tissue damage
if a different aldehyde pattern occurs. There is the
possibility that in CBrC13 induced liver damage
4-hydroxynonenal and similar aldehydic products of
lipid peroxidation are involved in cell damage and
act as mediators of inflammatory processes. The
relation between formation and ’consumption’ of
aldehydes should be investigated in further
experiments.
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